• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球成人流感相关下呼吸道感染和住院负担:系统评价和荟萃分析。

Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.

机构信息

Influenza Division, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.

Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland.

出版信息

PLoS Med. 2021 Mar 1;18(3):e1003550. doi: 10.1371/journal.pmed.1003550. eCollection 2021 Mar.

DOI:10.1371/journal.pmed.1003550
PMID:33647033
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7959367/
Abstract

BACKGROUND

Influenza illness burden is substantial, particularly among young children, older adults, and those with underlying conditions. Initiatives are underway to develop better global estimates for influenza-associated hospitalizations and deaths. Knowledge gaps remain regarding the role of influenza viruses in severe respiratory disease and hospitalizations among adults, particularly in lower-income settings.

METHODS AND FINDINGS

We aggregated published data from a systematic review and unpublished data from surveillance platforms to generate global meta-analytic estimates for the proportion of acute respiratory hospitalizations associated with influenza viruses among adults. We searched 9 online databases (Medline, Embase, CINAHL, Cochrane Library, Scopus, Global Health, LILACS, WHOLIS, and CNKI; 1 January 1996-31 December 2016) to identify observational studies of influenza-associated hospitalizations in adults, and assessed eligible papers for bias using a simplified Newcastle-Ottawa scale for observational data. We applied meta-analytic proportions to global estimates of lower respiratory infections (LRIs) and hospitalizations from the Global Burden of Disease study in adults ≥20 years and by age groups (20-64 years and ≥65 years) to obtain the number of influenza-associated LRI episodes and hospitalizations for 2016. Data from 63 sources showed that influenza was associated with 14.1% (95% CI 12.1%-16.5%) of acute respiratory hospitalizations among all adults, with no significant differences by age group. The 63 data sources represent published observational studies (n = 28) and unpublished surveillance data (n = 35), from all World Health Organization regions (Africa, n = 8; Americas, n = 11; Eastern Mediterranean, n = 7; Europe, n = 8; Southeast Asia, n = 11; Western Pacific, n = 18). Data quality for published data sources was predominantly moderate or high (75%, n = 56/75). We estimate 32,126,000 (95% CI 20,484,000-46,129,000) influenza-associated LRI episodes and 5,678,000 (95% CI 3,205,000-9,432,000) LRI hospitalizations occur each year among adults. While adults <65 years contribute most influenza-associated LRI hospitalizations and episodes (3,464,000 [95% CI 1,885,000-5,978,000] LRI hospitalizations and 31,087,000 [95% CI 19,987,000-44,444,000] LRI episodes), hospitalization rates were highest in those ≥65 years (437/100,000 person-years [95% CI 265-612/100,000 person-years]). For this analysis, published articles were limited in their inclusion of stratified testing data by year and age group. Lack of information regarding influenza vaccination of the study population was also a limitation across both types of data sources.

CONCLUSIONS

In this meta-analysis, we estimated that influenza viruses are associated with over 5 million hospitalizations worldwide per year. Inclusion of both published and unpublished findings allowed for increased power to generate stratified estimates, and improved representation from lower-income countries. Together, the available data demonstrate the importance of influenza viruses as a cause of severe disease and hospitalizations in younger and older adults worldwide.

摘要

背景

流感疾病负担巨大,尤其是在幼儿、老年人和有基础疾病的人群中。目前正在努力制定更好的全球估计数,以了解与流感相关的住院和死亡情况。关于流感病毒在全球范围内成年人严重呼吸道疾病和住院治疗中的作用,仍存在知识空白,尤其是在低收入国家。

方法和发现

我们汇总了系统评价中已发表的数据和监测平台中未发表的数据,以生成全球关于成年人中与流感病毒相关的急性呼吸道住院的比例的meta 分析估计数。我们在 9 个在线数据库(Medline、Embase、CINAHL、Cochrane Library、Scopus、全球卫生、LILACS、WHOLIS 和 CNKI;1996 年 1 月 1 日至 2016 年 12 月 31 日)中搜索了与成年人流感相关住院的观察性研究,并使用简化的纽卡斯尔-渥太华量表对合格论文进行了偏倚评估。我们应用 meta 分析比例对全球疾病负担研究中成年人下呼吸道感染(LRIs)和住院的全球估计数进行了分析,根据年龄组(20-64 岁和≥65 岁)对成年人≥20 岁的 LRI 发生率和住院率进行了分析,以获得 2016 年与流感相关的 LRI 发作和住院的数量。来自 63 个来源的数据表明,流感与所有成年人中 14.1%(95%CI,12.1%-16.5%)的急性呼吸道住院相关,且按年龄组无显著差异。63 个数据源代表了来自所有世界卫生组织区域(非洲,n=8;美洲,n=11;东地中海,n=7;欧洲,n=8;东南亚,n=11;西太平洋,n=18)的已发表观察性研究(n=28)和未发表的监测数据(n=35)。发表数据来源的质量主要为中等到高(75%,n=56/75)。我们估计每年有 3212.6 万(95%CI,2048.4 万至 4612.9 万)与流感相关的 LRI 发作和 567.8 万(95%CI,320.5 万至 943.2 万)与流感相关的 LRI 住院。虽然<65 岁的成年人在与流感相关的 LRI 住院和发作中占大多数(346.4 万[95%CI,188.5 万至 597.8 万]LRI 住院和 3108.7 万[95%CI,199.87 万至 4444.4 万]LRI 发作),但≥65 岁人群的住院率最高(437/100000 人年[95%CI,265-612/100000 人年])。对于这项分析,发表的文章在按年份和年龄组分层检测数据的纳入方面存在局限性。研究人群中关于流感疫苗接种的信息缺乏也是这两种数据源的一个局限。

结论

在这项 meta 分析中,我们估计全球每年与流感相关的住院人数超过 500 万例。纳入已发表和未发表的研究结果,增加了分层估计的能力,并提高了来自低收入国家的代表性。现有数据共同表明,流感病毒是全球范围内年轻人和老年人发生严重疾病和住院的重要原因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ed/7959367/441e126a91a7/pmed.1003550.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ed/7959367/16962367c555/pmed.1003550.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ed/7959367/441e126a91a7/pmed.1003550.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ed/7959367/16962367c555/pmed.1003550.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b3ed/7959367/441e126a91a7/pmed.1003550.g002.jpg

相似文献

1
Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.全球成人流感相关下呼吸道感染和住院负担:系统评价和荟萃分析。
PLoS Med. 2021 Mar 1;18(3):e1003550. doi: 10.1371/journal.pmed.1003550. eCollection 2021 Mar.
2
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.全球、区域和国家非 COVID-19 下呼吸道感染及病因的发病率、死亡率负担,1990-2021 年:来自 2021 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2024 Sep;24(9):974-1002. doi: 10.1016/S1473-3099(24)00176-2. Epub 2024 Apr 15.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis.1982 - 2012年流感在儿童呼吸道住院治疗中的全球作用及负担:一项系统分析
PLoS Med. 2016 Mar 24;13(3):e1001977. doi: 10.1371/journal.pmed.1001977. eCollection 2016 Mar.
5
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计:系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
6
Age-sex differences in the global burden of lower respiratory infections and risk factors, 1990-2019: results from the Global Burden of Disease Study 2019.年龄性别差异与下呼吸道感染全球负担及相关风险因素,1990-2019 年:基于 2019 年全球疾病负担研究结果
Lancet Infect Dis. 2022 Nov;22(11):1626-1647. doi: 10.1016/S1473-3099(22)00510-2. Epub 2022 Aug 11.
7
Uncovering the Burden of Influenza-Associated Illness across Levels of Severity in the Kingdom of Saudi Arabia Across Three Seasons.揭示沙特阿拉伯王国三个季节中不同严重程度的流感相关疾病负担。
J Epidemiol Glob Health. 2025 Mar 20;15(1):47. doi: 10.1007/s44197-025-00390-1.
8
The burden of influenza-associated respiratory hospitalizations in Bhutan, 2015-2016.2015-2016 年不丹流感相关呼吸道住院负担。
Influenza Other Respir Viruses. 2019 Jan;13(1):28-35. doi: 10.1111/irv.12605. Epub 2018 Oct 23.
9
Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study.2018 年全球 5 岁以下儿童人偏肺病毒急性下呼吸道感染负担:系统评价和建模研究。
Lancet Glob Health. 2021 Jan;9(1):e33-e43. doi: 10.1016/S2214-109X(20)30393-4. Epub 2020 Nov 26.
10
Burden of influenza-associated respiratory hospitalizations in the Americas, 2010-2015.2010-2015 年美洲因流感相关呼吸道疾病住院的负担。
PLoS One. 2019 Sep 6;14(9):e0221479. doi: 10.1371/journal.pone.0221479. eCollection 2019.

引用本文的文献

1
Chinese Medicine Strategies for Influenza A: Research Progress and Prospects.甲型流感的中医防治策略:研究进展与展望
Chin J Integr Med. 2025 Aug 11. doi: 10.1007/s11655-025-3941-7.
2
Incidence of Human Metapneumovirus Among Older Adults in 10 High-Income Countries: A Systematic Literature Review, Meta-analysis, and Modeling Study.10个高收入国家老年人中人间偏肺病毒的发病率:一项系统文献综述、荟萃分析和建模研究
Open Forum Infect Dis. 2025 Jul 18;12(7):ofaf373. doi: 10.1093/ofid/ofaf373. eCollection 2025 Jul.
3
Why do older adults hesitate to get the flu vaccine? A cross-sectional study on vaccine hesitancy in the post-COVID-19 era.

本文引用的文献

1
The partnership for influenza vaccine introduction (PIVI): Supporting influenza vaccine program development in low and middle-income countries through public-private partnerships.流感疫苗引入伙伴关系(PIVI):通过公私伙伴关系支持低收入和中等收入国家的流感疫苗规划发展。
Vaccine. 2019 Aug 14;37(35):5089-5095. doi: 10.1016/j.vaccine.2019.06.049. Epub 2019 Jul 6.
2
Incidence of hospitalisation for severe complications of influenza virus infection in Japanese patients between 2012 and 2016: a cross-sectional study using routinely collected administrative data.2012 年至 2016 年期间日本患者因流感病毒感染导致严重并发症住院的发生率:一项使用常规收集的行政数据的横断面研究。
BMJ Open. 2019 Jan 17;9(1):e024687. doi: 10.1136/bmjopen-2018-024687.
3
为什么老年人在接种流感疫苗时会犹豫不决?一项关于新冠疫情后时代疫苗犹豫情况的横断面研究。
Front Public Health. 2025 Jul 2;13:1603091. doi: 10.3389/fpubh.2025.1603091. eCollection 2025.
4
Safety and Immunogenicity of OVX836, a Nucleoprotein-Based Universal Influenza Vaccine, Co-Administered with Fluarix Tetra, a Seasonal Hemagglutinin-Based Vaccine.基于核蛋白的通用流感疫苗OVX836与基于季节性血凝素的疫苗Fluarix Tetra联合使用的安全性和免疫原性。
Vaccines (Basel). 2025 May 23;13(6):558. doi: 10.3390/vaccines13060558.
5
Epigenetic changes and serotype-specific responses of alveolar type II epithelial cells to Streptococcus pneumoniae in resolving influenza A virus infection.在甲型流感病毒感染消退过程中,肺泡II型上皮细胞对肺炎链球菌的表观遗传变化和血清型特异性反应。
Cell Commun Signal. 2025 Jun 12;23(1):278. doi: 10.1186/s12964-025-02284-y.
6
The association between influenza infection and acute myocardial infarction: A comprehensive systematic review and meta-analysis.流感感染与急性心肌梗死之间的关联:一项全面的系统评价和荟萃分析。
Virus Res. 2025 Jun 9;358:199594. doi: 10.1016/j.virusres.2025.199594.
7
Safety evaluation of baloxavir marboxil: analysis and discussion utilizing real adverse events from the FAERS database.玛巴洛沙韦的安全性评估:利用来自FAERS数据库的真实不良事件进行分析与讨论
BMC Pharmacol Toxicol. 2025 May 26;26(1):110. doi: 10.1186/s40360-025-00940-0.
8
Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myeloma.多发性骨髓瘤患者接种一剂与两剂甲型/乙型流感疫苗后的免疫反应。
Ann Hematol. 2025 May;104(5):2813-2821. doi: 10.1007/s00277-025-06367-1. Epub 2025 May 15.
9
Co-Administration of BNT162b2 COVID-19 and Influenza Vaccines in Adults: A Global Systematic Review.成人中BNT162b2新冠疫苗与流感疫苗的联合接种:一项全球系统评价
Vaccines (Basel). 2025 Apr 2;13(4):381. doi: 10.3390/vaccines13040381.
10
A 14-year influenza reinfection surveillance in Chongqing, China: A retrospective analysis.中国重庆14年流感再感染监测:一项回顾性分析。
Hum Vaccin Immunother. 2025 Dec;21(1):2497576. doi: 10.1080/21645515.2025.2497576. Epub 2025 May 5.
Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017.2017 年流感导致的下呼吸道感染所致死亡率、发病率和住院治疗负担:2017 年全球疾病负担研究分析。
Lancet Respir Med. 2019 Jan;7(1):69-89. doi: 10.1016/S2213-2600(18)30496-X. Epub 2018 Dec 12.
4
Progress and Remaining Gaps in Estimating the Global Disease Burden of Influenza.估算全球流感疾病负担的进展和遗留差距。
Emerg Infect Dis. 2018 Jul;24(7):1173-1177. doi: 10.3201/eid2407.171270.
5
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.全球季节性流感相关呼吸道死亡率的估计:一项建模研究。
Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14.
6
Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial.高剂量与标准剂量流感疫苗接种对美国养老院居民住院人数的影响比较:一项整群随机试验。
Lancet Respir Med. 2017 Sep;5(9):738-746. doi: 10.1016/S2213-2600(17)30235-7. Epub 2017 Jul 20.
7
Effectiveness of MF59-adjuvanted seasonal influenza vaccine in the elderly: A systematic review and meta-analysis.MF59佐剂季节性流感疫苗在老年人中的有效性:一项系统评价和荟萃分析。
Vaccine. 2017 Jan 23;35(4):513-520. doi: 10.1016/j.vaccine.2016.12.011. Epub 2016 Dec 23.
8
Current Approaches for Diagnosis of Influenza Virus Infections in Humans.目前人类流感病毒感染的诊断方法
Viruses. 2016 Apr 12;8(4):96. doi: 10.3390/v8040096.
9
Global Role and Burden of Influenza in Pediatric Respiratory Hospitalizations, 1982-2012: A Systematic Analysis.1982 - 2012年流感在儿童呼吸道住院治疗中的全球作用及负担:一项系统分析
PLoS Med. 2016 Mar 24;13(3):e1001977. doi: 10.1371/journal.pmed.1001977. eCollection 2016 Mar.
10
Meeting of the Strategic Advisory Group of Experts on immunization, April 2012--conclusions and recommendations.免疫战略咨询专家组会议,2012年4月——结论与建议
Wkly Epidemiol Rec. 2012 May 25;87(21):201-16.